Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 8.72% is 29% above its 5-year average of 6.78%, near the high end of its 5-year range (0.00%–8.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.09% above its 12-month average of 8.15%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.72%.
DEBT TO ASSETS RATIO
8.72%
DEBT TO ASSETS RATIO AVG TTM
8.15%
DEBT TO ASSETS RATIO AVG 3Y
7.28%
DEBT TO ASSETS RATIO AVG 5Y
6.78%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.09%
CURRENT VS 3Y AVG
+19.91%
CURRENT VS 5Y AVG
+28.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+9593.72%
vs the sector median at left
Market Cap
$120.92M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.48M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.61M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.68M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$117.28M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$125.14M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seer, Inc. (SEER) | $121.19M | 8.72% | 8.15% | 7.28% | 6.78% |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | 0.12% | N/A | N/A | N/A |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.48M | 0.04% | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $122.13M | 0.10% | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.61M | 0.07% | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $119.26M | 0.00% | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.68M | 0.00% | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $117.28M | 0.00% | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.14M | 0.01% | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $125.37M | 0.01% | N/A | N/A | N/A |
Debt/Assets
8.7%
Debt/Equity
0.10
Current Ratio
14.74
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 8.72% |
| 2026-03-31 | 8.46% |
| 2025-12-31 | 7.99% |
| 2025-09-30 | 7.86% |
| 2025-06-30 | 7.70% |
| 2025-03-31 | 7.32% |
| 2024-12-31 | 7.08% |
| 2024-09-30 | 6.91% |
| 2024-06-30 | 6.66% |
| 2024-03-31 | 6.56% |
| 2023-12-31 | 6.48% |
| 2023-09-30 | 6.48% |
| 2023-06-30 | 6.36% |
| 2023-03-31 | 6.32% |
| 2022-12-31 | 6.12% |
| 2022-09-30 | 5.96% |
| 2022-06-30 | 5.82% |
| 2022-03-31 | 5.73% |
| 2021-12-31 | 4.33% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2019-12-31 | 0.00% |
